Royalty Pharma 

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$621,990
$609,291
$578,665
$568,247
Gross Profit
621,990
609,291
578,665
568,247
EBITDA
451,280
525,052
159,303
498,694
EBIT
450,084
523,775
209,799
534,182
Net Income
214,205
288,217
30,176
238,349
Net Change In Cash
621,990
609,291
578,665
568,247
Free Cash Flow
827,148
702,615
363,984
596,076
Cash
619,000
938,944
631,908
1,087,720
Basic Shares
559,611
559,611
562,298
578,102

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$2,378,193
$2,263,576
$2,354,554
$2,237,215
Gross Profit
2,378,193
2,263,576
2,354,554
2,237,215
EBITDA
1,635,708
1,556,325
1,887,275
423,695
EBIT
1,631,856
1,292,444
1,492,150
418,025
Net Income
770,947
858,983
1,134,834
42,832
Net Change In Cash
2,378,193
2,263,576
2,354,554
2,237,215
Cost of Revenue
169,703
Free Cash Flow
2,489,823
2,768,986
2,987,802
4,185,132
Cash
618,696
929,026
477,010
1,710,751
Basic Shares
559,611
594,000
602,900
437,972

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
$0.38
2025-09-30
$1.17
2025-06-30
$1.14